OtherCellular & Molecular
Nateglinide, a D-phenylalanine derivative lacking either a sulfonylurea or benzamido moiety, specifically inhibits pancreatic β-cell-type KATP channels
Motohiko Chachin, Mitsuhiko Yamada, Akikazu Fujita, Tetsuro Matsuoka, Kenji Matsushita and Yoshihisa Kurachi
Journal of Pharmacology and Experimental Therapeutics November 25, 2002, DOI: https://doi.org/10.1124/jpet.102.044917
Motohiko Chachin
Mitsuhiko Yamada
Akikazu Fujita
Tetsuro Matsuoka
Kenji Matsushita
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
OtherCellular & Molecular
Nateglinide, a D-phenylalanine derivative lacking either a sulfonylurea or benzamido moiety, specifically inhibits pancreatic β-cell-type KATP channels
Motohiko Chachin, Mitsuhiko Yamada, Akikazu Fujita, Tetsuro Matsuoka, Kenji Matsushita and Yoshihisa Kurachi
Journal of Pharmacology and Experimental Therapeutics November 25, 2002, DOI: https://doi.org/10.1124/jpet.102.044917
OtherCellular & Molecular
Nateglinide, a D-phenylalanine derivative lacking either a sulfonylurea or benzamido moiety, specifically inhibits pancreatic β-cell-type KATP channels
Motohiko Chachin, Mitsuhiko Yamada, Akikazu Fujita, Tetsuro Matsuoka, Kenji Matsushita and Yoshihisa Kurachi
Journal of Pharmacology and Experimental Therapeutics November 25, 2002, DOI: https://doi.org/10.1124/jpet.102.044917
Jump to section
Related Articles
Cited By...
Similar Articles
Advertisement